MANSON Shines at Dubai Derma 2024: Pioneering Regenerative Solutions on the Global Stage

Dubai, UAE – March 2024

MANSON, a leading innovator in medical aesthetics and regenerative technologies, concluded its highly successful participation in Dubai Derma 2024, the Middle East’s largest dermatology and aesthetic medicine exhibition. Held at the Dubai World Trade Centre from March 1–3, the event attracted over 25,000 attendees from 130+ countries, including clinicians, distributors, and industry leaders. This year’s showcase marked MANSON’s 5th consecutive appearance, reinforcing its commitment to advancing global healthcare partnerships.

A Legacy of Innovation Meets Global Demand

As a 25-year veteran in international OEM/ODM collaborations, MANSON unveiled its 2024 product line, headlined by next-generation PRP Tubes with Biocompatible Gel Technology and the VIRTUOSE PCF04 Automated Centrifuge. The exhibition space, spanning 120 sqm, featured interactive demos and live protocol workshops, drawing record foot traffic.

Key Highlights:

1,800+ Professional Engagements: Clinicians from Saudi Arabia, India, and Europe explored MANSON’s CE/FDA-certified PRP kits.

52 Letters of Intent Signed: Including partnerships with UAE’s largest medical distributor and a Riyadh-based hospital chain.

Live Demo Success: Over 300 attendees participated in hands-on sessions for PRP Facial Rejuvenation and Veterinary Orthopedic Applications.

Breakthrough Technologies Unveiled

1. PRP Tubes with Hyaluronic Acid Infusion

A first-to-market innovation combining platelet concentration with HA’s moisturizing benefits:

Dual-Action: Stimulates collagen while reducing transepidermal water loss.

Certifications: CE Class IIb, ISO 13485:2023 compliant.

Clinical Data: Trials show 35% faster epidermal repair vs. standard PRP.

2. Smart Centrifuge

Designed for high-volume clinics:

AI-Powered Protocols: Auto-adjusts spin speed (200–4,500 RPM) based on blood viscosity.

Cross-Contamination Safeguard: Patented single-use rotor system.

Market Readiness: Launches Q3 2024 with pre-orders exceeding 1,200 units at the show.

Client Voices: Why MANSON Stands Out

“MANSON’s customizable PRP tubes allowed us to brand kits for our Middle Eastern clientele seamlessly. Their MOQ of 500 units makes them ideal for growing markets.”

*“The HA-infused tubes are revolutionary for desert climates like ours, where skin hydration is critical. We’ve placed a trial order for 2,000 units.”*

Strategic Partnerships Forged

GCC Veterinary Alliance: MANSON will supply species-specific PRP kits for camel and racehorse therapies, addressing the region’s $900M+ animal healthcare market.

Telemedicine Integration: Partnered with Dubai-based HealthTech AI to develop PRP protocol training modules for remote practitioners.

Sustainability Pledge: Announced 100% recyclable packaging by 2025, aligning with UAE’s Circular Economy Agenda 2031.

Trend Forecast: 62% growth in MENA’s regenerative aesthetics market by 2027 (Frost & Sullivan data).

Case Study: 89% patient satisfaction using MANSON’s PRP+HA tubes for acne scars in humid climates.

Road Ahead: From Dubai to the World

Building on Dubai Derma’s momentum, MANSON announces:

Q2 2024: Launch of PRP Mobile Labs in Egypt and Morocco for on-site clinician training.

Q4 2024: Participation in Aesthetic Academy Summit in Riyadh, featuring live horse tendon repair demos.